Cyclosporiasis: What family physicians need to know
-
Symptoms resemble many common gastrointestinal illnesses (e.g., viral gastroenteritis, food poisoning, medication side effect, C. diff infection). Any patient with prolonged or relapsing watery diarrhea should prompt consideration of Cyclospora, especially during summer produce-associated outbreak season, even if initial testing is negative.
-
Fresh produce remains a common source of exposure. Washing produce is a recommended food safety practice, but it cannot be relied upon to eliminate Cyclospora contamination.
-
Specifically request Cyclospora laboratory testing on stool specimens because routine stool culture and ova and parasite (O&P) examinations do not reliably detect the parasite. Molecular (PCR-based) diagnostic testing or Cyclospora smear are usually needed for detection.
-
Physicians should report cases to their local Health Department.
Typical incubation:
Approximately 1 week after exposure
Range: 2 to 14 days
No reported human-to-human transmission. (Oocysts shed in the stool are not immediately infectious.)
Consider Cyclospora in patients with:
-
Watery diarrhea lasting longer than >7 days
-
Relapsing or intermittent symptoms after initial improvement
-
Recent consumption of fresh produce, and/or other family members reporting illness after eating fresh produce (e.g, raspberries, lettuce).
-
Negative initial stool studies
-
Illness occurring during spring and summer outbreak season
Common diagnostic pitfalls:
Routine stool culture or O&P testing may miss Cyclospora.
-
Not all GI PCR panels detect Cyclospora.
-
Physicians may need to specifically request Cyclospora testing, which can be expensive and may not be covered by insurance.
-
Multiple stool specimens collected on different days may be needed; false reassurance from a single negative stool test is common.
-
Testing is not performed on formed stool.
First-line treatment: TMP-SMX remains the treatment of choice.
-
Treat confirmed cases of cyclosporiasis with trimethoprim-sulfamethoxazole (TMP-SMX) for immunocompetent adults; consider longer courses (3-4 weeks) or higher frequency dosing (3-4 times daily) for patients with immunocompromising conditions.
-
Standard adult dosing: TMP 160 mg/SMX 800 mg, orally twice daily, 7-10 days.
-
Though TMP-SMX is considered the treatment of choice for pediatric patients over age 2 months, it is not currently FDA-approved. Dosing is weight-based.
-
Treatment shortens course of symptoms, but Cyclospora infections can be self-resolving.
Additional Considerations: Illness may persist for weeks if untreated and symptoms may relapse.
Limited evidence suggests sulfa-allergic patients may use ciprofloxacin (500mg orally twice daily) or nitazoxanide (500mg orally twice daily, 3 days). If other options fail, pyrimethamine and folinic acid (used to treat cystoisosporiasis in sulfa-allergic patients) could be considered.
Cyclospora won’t be the last outbreak to test your readiness.
Today’s infectious disease challenges can appear with little warning. The AAFP Addressing Reemerging Infectious Conditions Livestream provides the clinical framework to help you recognize emerging and reemerging infectious conditions, make informed diagnostic decisions and know when and how to involve public health partners.
References
Clinical Guidance for Cyclosporiasis | Cyclosporiasis | CDC
Surveillance of Cyclosporiasis | Cyclosporiasis | CDC
Domestically Acquired Cyclosporiasis Cases in Multiple U.S. States, 2026 | HAN | CDC
Clinical Care of Cyclosporiasis | Cyclosporiasis | CDC
Cyclosporiasis - Surveillance and Investigation
Red Book Online Outbreaks: Cyclosporiasis Outbreak | Red Book Online | American Academy of Pediatrics
